Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Greenbrae › NPI 1396725677
Hospital

Marin General Hospital

Marin General Hospital was paid $46.42M by Medicaid between Jan 2018 and Nov 2024, across 236 billing codes. Its largest line is 99283, emergency room visit (moderate) — 12% of everything it billed.

33Billing provider infoMARIN GENERAL HOSPITAL
GREENBRAE, CA 94904
33aNPI1396725677assigned 01/20/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$46.42M
24GClaims622,400
24DCodes billed236
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#67 of 410
Median peer was paid$6.90M
This provider vs. median6.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201876,384$4.63M
201980,625$5.15M
202063,335$4.46M
202182,216$5.96M
202298,712$7.83M
2023122,561$10.42M
2024incomplete98,567$7.98M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 12% 55,154 44,429 $5.68M
99281 Emergency department visit for the evaluation and management, self-limited or minor 12% 39,881 33,160 $5.35M
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 8.3% 7,181 4,614 $3.87M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.5% 3,954 3,692 $2.10M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.5% 24,703 6,407 $1.64M
77067 Screening mammography, bilateral, including computer-aided detection 3.1% 5,662 5,532 $1.42M
70450 Computed tomography, head or brain; without contrast material 2.4% 3,899 3,596 $1.13M
99201 2.3% 4,135 2,888 $1.07M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.2% 8,097 7,049 $1.04M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2.2% 7,095 6,307 $1.01M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2.0% 2,899 2,822 $916K
97750 2.0% 7,882 3,985 $913K
224 more codes
76700 Ultrasound, abdominal, real time with image documentation; complete 1.8% 4,790 $838K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.7% 13,549 $791K
J3490 Unclassified drugs 1.7% 46,866 $784K
93975 1.5% 1,454 $683K
97139 1.4% 15,548 $649K
96375 Therapeutic injection; each additional sequential IV push 1.4% 7,818 $649K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1.3% 3,993 $612K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.3% 3,685 $597K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 1.2% 4,297 $555K
71260 Computed tomography, thorax, diagnostic; with contrast material 1.1% 862 $521K
92557 1.1% 2,729 $503K
76830 Ultrasound, transvaginal 1.1% 3,281 $503K
72125 Computed tomography, cervical spine; without contrast material 1.0% 1,018 $477K
59025 Fetal non-stress test <1% 9,295 $404K
99070 <1% 16,297 $351K
96361 Intravenous infusion, hydration; each additional hour <1% 4,490 $348K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 626 $340K
77063 Screening digital breast tomosynthesis, bilateral <1% 5,603 $333K
77066 Tomosynthesis, mammo <1% 1,032 $315K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 417 $288K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 269 $285K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 3,599 $267K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,364 $248K
96367 <1% 1,934 $238K
90791 Psychiatric diagnostic evaluation <1% 709 $236K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,807 $236K
J2704 Injection, propofol, 10 mg <1% 6,371 $233K
76642 <1% 1,728 $224K
71045 Radiologic examination, chest; single view <1% 8,549 $218K
80053 Comprehensive metabolic panel <1% 23,795 $208K
93971 <1% 844 $203K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,808 $195K
70551 Magnetic resonance imaging, brain; without contrast material <1% 322 $180K
93351 <1% 387 $179K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,913 $172K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 26,311 $169K
77065 Tomosynthesis, mammo <1% 726 $168K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 7,021 $167K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,992 $164K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,889 $161K
93976 <1% 369 $159K
Z7502 <1% 4,161 $157K
71046 Radiologic examination, chest; 2 views <1% 3,838 $152K
76770 <1% 779 $132K
96415 <1% 1,146 $131K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 1,693 $122K
A9585 Injection, gadobutrol, 0.1 ml <1% 1,408 $119K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 6,187 $119K
93325 <1% 392 $117K
73610 <1% 1,904 $117K
72141 <1% 205 $116K
73030 <1% 1,922 $116K
93990 <1% 714 $113K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 427 $110K
97803 <1% 873 $108K
73630 <1% 1,874 $107K
87631 <1% 1,198 $106K
73564 <1% 1,544 $105K
J7030 Infusion, normal saline solution , 1000 cc <1% 8,764 $97K
70486 <1% 266 $95K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 9,179 $94K
73221 <1% 138 $93K
73130 <1% 1,446 $89K
72100 <1% 1,293 $86K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 887 $86K
71275 Computed tomographic angiography, chest, with contrast material <1% 156 $81K
J7120 Ringers lactate infusion, up to 1000 cc <1% 7,405 $77K
93970 <1% 200 $75K
71250 <1% 240 $75K
92585 <1% 117 $71K
73110 <1% 1,157 $70K
76536 <1% 572 $69K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 439 $68K
70496 <1% 132 $66K
70498 <1% 127 $63K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 722 $63K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 681 $62K
Z9725 <1% 1,429 $61K
84484 <1% 7,139 $61K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 927 $55K
0450 Emergency room services <1% 1,372 $53K
76801 <1% 353 $51K
92587 <1% 356 $50K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,505 $49K
73502 <1% 745 $49K
83690 <1% 8,494 $48K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 101 $47K
81001 <1% 8,625 $46K
J0690 Injection, cefazolin sodium, 500 mg <1% 3,423 $46K
93320 <1% 244 $44K
J2469 Injection, palonosetron hcl, 25 mcg <1% 532 $42K
92567 <1% 462 $41K
72110 <1% 374 $40K
77049 <1% 56 $39K
73562 <1% 721 $38K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 5,097 $37K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,381 $35K
73140 <1% 915 $35K
74018 <1% 808 $33K
73080 <1% 496 $32K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 3,794 $31K
96417 <1% 307 $28K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 147 $27K
92550 <1% 525 $25K
90715 <1% 412 $25K
81025 <1% 6,906 $24K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,532 $24K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,073 $22K
73560 <1% 453 $22K
76857 <1% 277 $21K
83605 <1% 2,068 $20K
C9290 Injection, bupivacaine liposome, 1 mg <1% 67 $20K
76870 <1% 139 $18K
80305 <1% 1,477 $17K
82947 <1% 3,599 $17K
80048 Basic metabolic panel (calcium, ionized) <1% 2,511 $17K
S0302 Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) <1% 130 $17K
93017 <1% 92 $16K
99284 Emergency room visit (serious) <1% 97 $16K
81003 <1% 5,599 $16K
83880 <1% 601 $15K
87070 <1% 1,981 $15K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 129 $14K
84443 Thyroid stimulating hormone (TSH) <1% 1,110 $14K
87077 <1% 1,812 $13K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,280 $13K
72050 <1% 131 $13K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 506 $12K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 504 $12K
87040 <1% 1,054 $12K
92650 <1% 19 $12K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,543 $11K
72040 <1% 203 $11K
83735 <1% 2,112 $10K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,060 $10K
73590 <1% 194 $10K
87186 <1% 1,215 $10K
85610 <1% 2,888 $9K
77080 <1% 122 $9K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,331 $8K
85379 <1% 1,112 $8K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 55 $8K
A4217 Sterile water/saline, 500 ml <1% 655 $8K
92579 <1% 78 $8K
87632 <1% 62 $8K
86901 <1% 3,321 $8K
J3480 Injection, potassium chloride, per 2 meq <1% 137 $8K
86900 <1% 3,322 $8K
J7050 Infusion, normal saline solution, 250 cc <1% 4,078 $7K
J2060 Injection, lorazepam, 2 mg <1% 835 $7K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 755 $7K
Z5902 <1% 39 $6K
86850 <1% 2,527 $6K
85027 <1% 1,306 $6K
J1644 Injection, heparin sodium, per 1000 units <1% 276 $6K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 863 $5K
93880 <1% 26 $5K
73100 <1% 109 $5K
82330 <1% 457 $5K
81002 <1% 1,209 $5K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 837 $5K
Z7610 <1% 458 $4K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 83 $4K
72170 <1% 75 $4K
92522 <1% 16 $4K
84702 <1% 351 $4K
J1453 Injection, fosaprepitant, 1 mg <1% 49 $4K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 15 $4K
86140 <1% 949 $4K
77336 <1% 28 $4K
99199 Unlisted special service, procedure or report <1% 71 $3K
64483 <1% 12 $3K
83036 Hemoglobin; glycosylated (A1C) <1% 435 $3K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 68 $3K
76882 <1% 120 $3K
12001 <1% 55 $2K
84145 <1% 125 $2K
80051 <1% 409 $2K
82565 <1% 550 $2K
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 213 $2K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 59 $2K
84100 <1% 470 $2K
87641 <1% 62 $2K
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 163 $1K
J1756 Injection, iron sucrose, 1 mg <1% 27 $1K
85730 <1% 330 $1K
72082 <1% 12 $1K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 34 $1K
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 222 $1K
J3475 Injection, magnesium sulfate, per 500 mg <1% 163 $1K
84520 <1% 404 $1K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 48 $1K
87510 <1% 62 $926.92
87480 <1% 62 $926.92
87660 <1% 62 $926.92
J7060 5% dextrose/water (500 ml = 1 unit) <1% 969 $926.86
82962 <1% 264 $860.91
73070 <1% 16 $839.52
85014 <1% 332 $803.78
29125 <1% 47 $797.84
72070 <1% 12 $785.73
73090 <1% 14 $723.10
73565 <1% 14 $682.64
J0780 Injection, prochlorperazine, up to 10 mg <1% 80 $643.99
72020 <1% 14 $639.94
85652 <1% 308 $614.02
S0028 Injection, famotidine, 20 mg <1% 92 $480.20
96402 <1% 15 $469.11
85008 <1% 850 $356.07
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 46 $352.05
87147 <1% 74 $308.32
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 13 $275.53
82550 <1% 27 $226.42
87205 <1% 38 $113.57
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 18 $109.20
36415 Collection of venous blood by venipuncture <1% 336 $99.97
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 783 $45.63
85651 <1% 13 $24.70
A6250 Skin sealants, protectants, moisturizers, ointments, any type, any size <1% 782 $24.36
81005 <1% 17 $22.72
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 78 $21.33
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 101 $14.23
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 72 $3.14
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 14 $1.01

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDOMANICO, LEE (CHIEF EXEC. OFFICER)